Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline

Introduction: Cannabinoid hyperemesis syndrome (CHS) is an entity associated with cannabinoid overuse. CHS typically presents with cyclical vomiting, diffuse abdominal pain, and relief with hot showers. Patients often present to the emergency department (ED) repeatedly and undergo extensive evaluations including laboratory examination, advanced imaging, and in some cases unnecessary procedures. They are exposed to an array of pharmacologic interventions including opioids that not only lack evidence, but may also be harmful.This paper presents a novel treatment guideline that highlights the identification and diagnosis of CHS and summarizes treatment strategies aimed at resolution of symptoms, avoidance of unnecessary opioids, and ensuring patient safety.

Source: To view full treatment guideline click here for the Western Journal of Emergency Medicine.

To view the Scripps Mercy Emergency Department Chief Newsletter regarding CHS, click here.

Comments are closed.